Qilian International Holding Group Limited Interest Expense 2011-2026 | QLI

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Qilian International Holding Group Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
57.7 K	243 K	224 K	216 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
243 K	57.7 K	185 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	51 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	722 K	-	-	$ 866 M	China
Genfit SA GNFT	4.68 M	-	2.54 %	$ 160 B	France
Athira Pharma ATHA	1.24 M	-	-	$ 269 M	USA
BioNTech SE BNTX	14.2 M	-	-	$ 27.2 B	Germany
INmune Bio INMB	2.28 M	$ 1.52	-1.3 %	$ 37.6 M	USA
Exelixis EXEL	-198 K	$ 48.7	9.64 %	$ 13.2 B	USA
ACADIA Pharmaceuticals ACAD	1.82 M	$ 21.48	-3.89 %	$ 3.56 B	USA
Fortress Biotech FBIO	17.6 M	-	-	$ 71.1 M	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	3.49 M	$ 3.15	1.19 %	$ 655 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	-	-	$ 5.51 M	Israel
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	8 K	-	-	$ 28.6 M	USA
AlloVir ALVR	1.44 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	443 K	$ 24.17	3.2 %	$ 3.08 B	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	-27 K	-	-	$ 8.42 M	USA
Aravive ARAV	2.84 M	-	-13.39 %	$ 1.45 M	USA
CRISPR Therapeutics AG CRSP	86.6 M	$ 55.08	5.15 %	$ 4.95 B	Schweiz
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	36.7 M	$ 1.7	3.66 %	$ 452 M	Britain
Galapagos NV GLPG	1.03 M	$ 28.81	1.48 %	$ 2.69 B	Belgium